One American dies every hour from melanoma. Non-Hodgkin lymphoma claimed over 20,000 US lives in 2010. Yet FDA barriers are delaying approval of innovative approaches that could have saved these fellow human beings. While technological advances are routine in virtually all disciplines, clinical medicine is the exception. It has devolved into a bureaucratic monstrosity that suffocates innovation while rewarding the politically well connected. How much longer will Americans tolerate a system that is a proven failure?
Glucose: The Silent Killer